Federal Scrutiny of PBMS Intensifies
- On February 3, 2026
Federal attention on the pharmaceutical benefit manager (PBM) sector has increased markedly in recent weeks. On January 22, 2026, the U.S. House of Representatives approved the Consolidated Appropriations Act (CAA) for fiscal year 2026. This wide-ranging funding legislation includes multiple healthcare provisions, among them sweeping reforms aimed at PBM operations. The Senate passed the bill […]
Read More
